Skip to main content

Your search for “Oncology” returned 285 results

Patient First in Region to Receive New Treatment for Advanced Prostate Cancer

October 5, 2022

UC San Diego Health is the first hospital system in the region to offer a novel treatment option for patients with prostate cancer that has spread throughout the body and has not responded to other therapeutics.

Poison Drummer Rikki Rockett Cancer-Free Following Immunotherapy at UC San Diego Health

July 18, 2016

Rikki Rockett, drummer for the band Poison, got the best news of his life last week: his cancer is gone. Rockett was diagnosed with oral cancer more than a year ago. Several months ago, he came to Moores Cancer Center at UC San Diego Health, where he underwent experimental cancer…

Study: Breast Cancer Drug Shows Potential for Rare Appendix Cancer

October 16, 2024

UC San Diego School of Medicine researchers discover a groundbreaking oral breast cancer drug that is also effective in treating a rare form of appendix cancer.

New Drug for Blood Cancers Now in Five Phase II Clinical Trials

July 27, 2015

Researchers at University of California, San Diego School of Medicine have established the safety and dosing of a new drug for treating blood cancers. The findings are published online July 27 in The Lancet Haematology.

Califano Named New Director of Moores Cancer Center at UC San Diego Health

November 14, 2022

Joseph A. Califano III, MD, has been named director of Moores Cancer Center at UC San Diego Health.

Rock Tour “Text2Give” Supports Immunotherapy at UC San Diego Health

April 19, 2017

Rock star drummer Rikki Rockett feels very lucky to be on tour with his band, Poison. A year ago, he didn’t know if he would survive tongue cancer but after participating in an immunotherapy clinical trial at Moores Cancer Center at UC San Diego Health, he was declared cancer-free in…

Blacks Have Less Access to Cancer Specialists, Treatment

November 19, 2013

Researchers at the University of California, San Diego School of Medicine say metastatic colorectal cancer patients of African-American descent are less likely to be seen by cancer specialists or receive cancer treatments. This difference in treatment explains a large part of the 15 percent higher mortality experienced by African-American patients…

Old Drugs Find New Target For Treating Brain Tumor

November 18, 2011

Scientists at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center, in collaboration with colleagues in Boston and South Korea, say they have identified a novel gene mutation that causes at least one form of glioblastoma (GBM), the most common type of malignant…

Personalized Medicine Leads to Better Outcomes for Patients with Cancer

June 6, 2016

In a meta-analysis of hundreds of clinical trials involving thousands of patients, researchers at University of California San Diego School of Medicine report that therapeutic approaches using precision medicine, which emphasizes the use of individual genetics to refine cancer treatment, showed improved response and longer periods of disease remission, even…

Cancer Avatars for Personalized Medicine

May 21, 2014

Researchers at University of California, San Diego School of Medicine and Moores Cancer Center have used computer simulations of cancer cells – cancer avatars – to identify drugs most likely to kill cancer cells isolated from patients’ brain tumors.

Category navigation with Social links